Cocrystal Pharma Inc (NASDAQ:COCP)
| 2.26 Delayed Data As of May 26 |  +0.03 / +1.35%Today’s Change | 1.74 Today|||52-Week Range 6.24 | +15.90% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 192.0K | 201.0K | 101.0K | 50.0K | ||
| Operating Expenses | Gross Income | -192.0K | -201.0K | -101.0K | -50.0K | |
| General Expenses | 53.3M | 105.6M | 8.2M | 9.0M | ||
| Research And Development | 47.3M | 101.5M | 5.7M | 4.6M | ||
| Total Operating Expenses | 53.5M | 105.8M | 8.3M | 9.0M | ||
| Non-Operating Expenses | Operating Income | -53.5M | -105.8M | -8.3M | -9.0M | |
| Extraordinary Credit | 0.00 | 2.6M | 907.0K | 412.0K | ||
| Extraordinary Charge | -10.4M | -1.2M | 0.00 | -53.9M | ||
| Interest Expense On Debt | 0.00 | 0.00 | -- | 58.0K | ||
| Other Expenses | -1.6M | -1.0K | -138.0K | -60.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -65.4M | -104.3M | -7.5M | -62.6M | |
| Income Taxes | -15.2M | -29.4M | -6.9M | -13.6M | ||
| Net Income | -50.1M | -74.9M | -613.0K | -49.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 21.0M | 23.5M | 24.1M | 28.0M | |
| Shares To Calculate EPS Diluted | 21.0M | 23.5M | 24.1M | 28.0M | ||
| Earnings Per Share | EPS | -$2.40 | -$3.30 | -$0.90 | -$1.75 | |
| EPS Diluted | -$2.40 | -$3.30 | -$0.03 | -$1.75 | ||
